YOU HAVE QUESTIONS.
WE HAVE ANSWERS.

The following FAQs can help answer any questions you may still have about BRAVECTO®. If there is something more you want to know, you can always contact us for more information—or ask your veterinarian.

Dog & Cat FAQs

IS BRAVECTO RECOMMENDED BY VETERINARIANS?

Yes. BRAVECTO Chew and BRAVECTO Topical Solution for Dogs is vet recommended for puppies and dogs 6 months of age or older who weigh at least 4.4 lb.1,2 BRAVECTO Topical Solution for Cats is vet recommended for kittens and cats 6 months of age or older who weigh at least 2.6 lb.3

Dog FAQs

Cat FAQs

SEE IF YOUR VET CARRIES BRAVECTO®

By prescription only. Enter your ZIP code to see which veterinarians carry BRAVECTO. Start protecting your pet today.

Start today and your pet’s next BRAVECTO treatment would be:
September 17, 2019

SAVE MORE WITH BRAVECTO

As a single 12-week* treatment, BRAVECTO can be more cost-effective than monthly treatments. See how you can save even more with a special offer.

Save more image

Dogs over 123.0 lb should be administered the appropriate combination of chew or topical treatments.

Save more image

Cats over 27.5 lb. should be administered the appropriate combination of tubes.

For technical assistance or to report a suspected adverse drug reaction, contact Merck Animal Health at 1-800-224-5318.

BRAVECTO kills fleas and prevents flea infestations for 12 weeks. BRAVECTO Chew and BRAVECTO Topical Solution for Dogs kills ticks (black-legged tick, American dog tick, and brown dog tick) for 12 weeks and also kills lone star ticks for 8 weeks. BRAVECTO Topical Solution for Cats kills black-legged ticks for 12 weeks and American dog ticks for 8 weeks.

IMPORTANT SAFETY INFORMATION
BRAVECTO has not been shown to be effective for 12-weeks duration in puppies or kittens less than 6 months of age. BRAVECTO Chew: The most common adverse reactions recorded in clinical trials were vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. BRAVECTO is not effective against lone star ticks beyond 8 weeks of dosing. BRAVECTO Topical Solution for Dogs: The most common adverse reactions recorded in clinical trials were vomiting, hair loss, diarrhea, lethargy, decreased appetite, and moist dermatitis/rash. BRAVECTO is not effective against lone star ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. Use caution in dogs with a history of seizures. Seizures have been reported in dogs receiving fluralaner, even in dogs without a history of seizures. BRAVECTO Topical Solution for Cats: The most common adverse reactions recorded in clinical trials were vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. BRAVECTO is not effective against American dog ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. The safety of BRAVECTO has not been established in breeding, pregnant, and lactating cats. Use with caution in cats with a history of neurologic abnormalities. Neurologic abnormalities have been reported in cats receiving BRAVECTO, even in cats without a history of neurologic abnormalities.

References:
1. BRAVECTO Chew [prescribing information]. Madison, NJ: Merck Animal Health; 2014. 2. BRAVECTO Topical Solution for Dogs [prescribing information]. Madison, NJ: Merck Animal Health; 2016. 3. BRAVECTO Topical Solution for Cats [prescribing information]. Madison, NJ: Merck Animal Health; 2016. 4. Freedom of Information Summary, NADA 141-426. Approved May 15, 2014. 5. Freedom of Information Summary, NADA 141-459. Approved July 20, 2016. 6. Lavan et al. J Vet Sci Technol. 2017;8:439. 7. Dryden et al. Parasites & Vectors. 2015;8:364. 8. Dryden et al. Parasites & Vectors. 2018;11:422. 9. Burgio et al. Parasites & Vectors. 2016;9:626. 10. CAPC website, Guidelines–Ticks. Available at www.capcvet.org/guidelines/ticks/. Updated April 2017. Accessed December 20, 2018. 11. Walther et al. Parasites & Vectors. 2014;7:86. 12. Walther et al. Parasites & Vectors. 2014;7:481.

Buy Bravecto